May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Expression of synapse–specific proteins in the rat retina is altered by experimental diabetes
Author Affiliations & Notes
  • A.L. Cannon
    Department of Ophthalmology, Penn State College of Medicine, Hershey, PA
  • A.J. Barber
    Department of Ophthalmology, Penn State College of Medicine, Hershey, PA
  • Penn State Retina Research Group
    Department of Ophthalmology, Penn State College of Medicine, Hershey, PA
  • Footnotes
    Commercial Relationships  A.L. Cannon, None; A.J. Barber, None.
  • Footnotes
    Support  JDRF, PA Lions
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3236. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.L. Cannon, A.J. Barber, Penn State Retina Research Group; Expression of synapse–specific proteins in the rat retina is altered by experimental diabetes . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3236.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Previously we found that experimental diabetes in rats increased retinal cell apoptosis and after several months, the thickness of the inner plexiform layer and the number of retinal ganglion cells were significantly reduced (Barber et al, 1998, JCI, 102:783–791). These data suggested that diabetes induces a chronic neurodegeneration in the inner retina. The aim of this study was to determine how diabetes alters the expression of synapse–specific proteins in the retina. Methods: Male Sprague–Dawley rats were made diabetic by injection of streptozotocin (STZ) and sacrificed three months later. The content of the synaptic proteins synaptophysin, CaMKII, and phospho–CaMKII were quantified by immunoblotting whole retina lysates. Subunits of the N–methyl–D–aspartate (NMDA) receptor were quantified by immunoblotting synaptic plasma membrane fractions. The distribution of synaptophysin was also examined by immunohistochemistry. Results: STZ–diabetic rats had significantly higher blood glucose compared to controls (343.3±28.66 Vs 92.3±3.59 mg/dL, p<0.001) and weighed significantly less than controls (363.9±16.00 Vs 557.4±22.80 gm, p<0.001). Synaptophysin was significantly reduced by STZ–diabetes to approximately 75% of control values (p<0.05) but there was no change in total CaMKII, phospho–CaMKII or beta–actin in the same samples. Synaptophysin immunoreactivity was also diminished in cryostat sections of retinas from STZ–diabetic rats compared to controls. The content of the NMDA R2a subunit was also reduced in the synaptic plasma membrane fractions from STZ–diabetic rats, compared to controls (p<0.05). Conclusions: These data suggest that the content of a specific subset of synaptic proteins is reduced in the retinas of experimentally diabetic rats. Therefore, diabetes may influence individual features of synaptic function. Reduced vision in diabetic retinopathy may in part be due to the way these specific deficits compromise neurotransmisson in the retina.

Keywords: diabetic retinopathy • synapse • apoptosis/cell death 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×